Volume 15, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


This is a review of statistics relating to the cost of pharmaceuticals to the consumer in the United States. Its existence can be attributed to the rapidly rising expenditures for drugs, a rise which has accelerated with governmental subsidy of medical care and which may be expected to continue to accelerate with additional subsidy. The Welfare Administration, naturally concerned over the draining off of welfare funds to pay for drugs which could perhaps be purchased at a lower cost, instigated the study resulting in the present report.

Although the large amount of statistical information will be of interest to some of the readers of the Journal, especially those engaged in clinical medicine or work with pharmaceuticals, it cannot be said that the problem has been fully presented nor has a reasonable solution been proposed.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error